Live
Funding 2 min read

Yazen Health raises EUR 50 million in funding

Verdane has led a EUR 50 million Series B in Yazen Health, backing the Swedish digital obesity-treatment company as it scales its combination of GLP-1 medications and multidisciplinary clinical support.

Image: Shifter

Yazen Health has successfully raised EUR 50 million in a Series B funding round led by Verdane. Founded in Lund in 2021, Yazen focuses on digital obesity treatment, incorporating GLP-1 medications alongside support from healthcare professionals, including doctors, nutritionists, and personal trainers.

The recent Series B funding is notably larger than previous rounds, being over two and a half times the size of the company’s Series A round, which secured €19.5 million in November 2024. Yazen Health previously announced plans for expansion into Spain, Norway, and the Netherlands, using those funds to support pilot projects in the UK and Germany.

With the completion of this funding round, Yazen Health is poised for significant growth, which may enhance its ability to attract new patients and bolster its digital treatment offerings across international markets.

Reporting sources

Where this story comes from

1 reference

The facts above are grounded in the original reporting linked here. Open the publisher story for its complete context.

ShifterNO source · English rendering Open source

Yazen Health raises EUR 50 million in funding

The available publisher preview does not add detail beyond this brief. Open the original report for its full context.

Related coverage

This story in context

Read the closer connections in publication order. Separate background links appear below.

You are reading this story

Later coverage 1

  1. Same event

    Swedish healthtech company lands €50 million to expand digital obesity care across Europe

    The review connects these reports to the same identifiable event. The source excerpts show the basis for the connection.

    ArcticStartup
    Why linked? View evidence
    Swedish healthtech company lands €50 million to expand digital obesity care across EuropeRecorded source excerpt · original wording
    Lund-based digital healthcare provider Yazen Health has secured €50 million in an investment partnership led by European growth investor Verdane, with Lund-based digital healthcare provider Yazen Health has secured €50 million in an investment partnership led by European growth investor Verdane , with participation from existing investor Evli Growth Partners (EGP) .
    ArcticStartup ↗
    Swedish healthtech company lands €50 million to expand digital obesity care across EuropeRecorded source excerpt · original wording
    Lund-based digital healthcare provider Yazen Health has secured €50 million in an investment partnership led by European growth investor Verdane, with Lund-based digital healthcare provider Yazen Health has secured €50 million in an investment partnership led by European growth investor Verdane , with participation ...
    ArcticStartup ↗
    Yazen Health raises EUR 50 million in fundingRecorded source excerpt · original wording
    Det Oslo-grunnlagte fondet går inn i svensk slankebehandling med en serie B på 50 millioner euro. Yazen Health har hentet 50 millioner euro, i underkant av 600 millioner kroner, i en serie B-runde ledet av Verdane. Yazen ble grunnlagt i Lund i 2021. Selskapet tilbyr digital fedmebehandling og kombinerer GLP-1-legemi...
    Shifter ↗
    Yazen Health raises EUR 50 million in fundingPublished article text · original wording
    Yazen Health raises EUR 50 million in funding
    Shifter ↗
About this history review

The link graph’s cryptographic signature was verified. This proves integrity, not the truth of every claim or complete archive coverage.

Graph updated . Only articles retained in the public archive are included.

Open technical link data
Method & transparencyHow this brief was selected and checked
Editorial priority7 / 10

Priority

Source coverageSingle-source report

Single-source report

ConfidenceLimited

45 / 100 · one source

Source basis

Grounded in the publisher material listed below.

Confirmation

No second independent source has been matched to this story yet.

Selection

Selected for publication after relevance, freshness and editorial-quality checks.

Selection factors

  • 1 independent source
  • 1 concrete event indicator
  • editorial priority

Source monitoring: 100% recent availability · No source-health warnings. The original publisher remains the authoritative source for the full report.